{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:36:29Z","timestamp":1781163389345,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.4158\/ep.6.5.385","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:37:07Z","timestamp":1365205027000},"page":"385-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Skeletal Effects of Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"6","author":[{"given":"Zeba","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.6.5.385_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4158\/EP.3.1.22","article-title":"Primary hyperparathyroidism: diagnosis and management","volume":"3","author":"Khan","year":"1997","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.6.5.385_bb0015","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI110570","article-title":"Differential effects of endocrine dysfunction on the axial and the appendicular skeleton","volume":"69","author":"Seeman","year":"1982","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.6.5.385_bb0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/17453678909149275","article-title":"Increased fracture risk in hypercalcemia: bone mineral content measured in hyperparathyroidism","volume":"60","author":"Larsson","year":"1989","journal-title":"Acta Orthop Scand"},{"key":"10.4158\/EP.6.5.385_bb0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP.6.5.385_bb0030","first-page":"3487","article-title":"Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"81","author":"Guo","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.6.5.385_bb0035","first-page":"112","article-title":"Total and regional bone mineral content in primary hyperparathyroidism: sex differences","volume":"20","author":"Rico","year":"1994","journal-title":"Miner Electrolyte Metab"},{"key":"10.4158\/EP.6.5.385_bb0040","first-page":"319","article-title":"Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism","volume":"127","author":"Pfeilschifter","year":"1992","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4158\/EP.6.5.385_bb0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.1994.tb03020.x","article-title":"Continuous combined oestrogen\/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis","volume":"40","author":"Grey","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.6.5.385_bb0050","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1365-2265.1996.744565.x","article-title":"Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism","volume":"44","author":"Grey","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.6.5.385_bb0055","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.6.5.385_bb0060","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.1992.00400230081014","article-title":"Risk of age-related fractures in patients with primary hyperparathyroidism","volume":"152","author":"Melton","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.6.5.385_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0039-6060(05)80017-0","article-title":"Fracture incidence in postmenopausal women with primary hyperparathyroidism","volume":"118","author":"Kenny","year":"1995","journal-title":"Surgery"},{"key":"10.4158\/EP.6.5.385_bb0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2796.1993.tb01017.x","article-title":"The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years","volume":"234","author":"Larsson","year":"1993","journal-title":"J Intern Med"},{"key":"10.4158\/EP.6.5.385_bb0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-83-3-365","article-title":"Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism","volume":"83","author":"Dauphine","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.6.5.385_bb0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-109-12-959","article-title":"Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures","volume":"109","author":"Wilson","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.6.5.385_bb0085","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1001\/archinte.1987.00370110079012","article-title":"What is the clinical significance of bone loss in primary hyperparathyroidism?","volume":"147","author":"Kochersberger","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.6.5.385_bb0090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism: a randomized, controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.6.5.385_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-95-1-23","article-title":"Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism","volume":"95","author":"Shane","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.6.5.385_bb0100","first-page":"S69","article-title":"Clodronate in the medical management of hyperparathyroidism","volume":"8(Suppl 1)","author":"Hamdy","year":"1987","journal-title":"Bone"},{"key":"10.4158\/EP.6.5.385_bb0105","first-page":"1067","article-title":"Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate","volume":"77","author":"Reasner","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.6.5.385_bb0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1990.tb00504.x","article-title":"Regulation of calci- um-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatmen","volume":"33","author":"Adami","year":"1990","journal-title":"Clin Endocrinol (Ox)"},{"key":"10.4158\/EP.6.5.385_bb0115","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1001\/jama.1983.03330390067035","article-title":"Treatment of hyperparathyroidism with etidronate disodium","volume":"249","author":"Licata","year":"1983","journal-title":"JAMA l"},{"key":"10.4158\/EP.6.5.385_bb0120","article-title":"Alendronate in the treatment of primary hyperparathyroidism-related osteoporosis [abstract]","author":"Parker","year":"1998","journal-title":"Presented at the Annual Meeting of the American Society of Bone and Mineral Research"},{"key":"10.4158\/EP.6.5.385_bb0125","article-title":"Alendronate therapy of primary hyperparathyroidism [abstract]","author":"el Hassani","year":"1998","journal-title":"Presented at the Annual Meeting of the Endocrine Society"},{"key":"10.4158\/EP.6.5.385_bb0130","first-page":"1","article-title":"Ca+2 receptor-dependent regulation of cellular function","volume":"10","author":"Nemeth","year":"1995","journal-title":"News Physiol Sci"},{"key":"10.4158\/EP.6.5.385_bb0135","first-page":"S175","article-title":"Calci- mimetics: structurally and mechanically novel compounds that inhibit hormone secretion from parathyroid cells [abstract]","volume":"8(Suppl 1)","author":"Steffey","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP.6.5.385_bb0140","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199711203372104","article-title":"Shortterm inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism","volume":"337","author":"Silverberg","year":"1997","journal-title":"NEngl J Med"},{"key":"10.4158\/EP.6.5.385_bb0145","first-page":"S9","article-title":"Consensus development conference statement","volume":"6(Suppl 2)","year":"1991","journal-title":"J Bone Miner Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/3H1TG8BW0G6C8VM3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:40:32Z","timestamp":1761514832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20419986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S1530891X20419986"],"URL":"https:\/\/doi.org\/10.4158\/ep.6.5.385","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal Effects of Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.6.5.385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}